Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

RETACRIT™ Principal Display Panel (epoetin alfa-epbx)

PRINCIPAL DISPLAY PANEL - 2,000 Units/mL Vial Label

NDC 0069-1305-01
Rx only

Retacrit™
Epoetin Alfa-epbx
recombinant

2,000 Units/mL

1 mL single-dose vial

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 2,000 Units/mL Vial Label

PRINCIPAL DISPLAY PANEL - 2,000 Units/mL Vial Carton

Retacrit™
Epoetin Alfa-epbx
recombinant

2,000 Units/mL

NDC 0069-1305-10
Rx only

ALWAYS DISPENSE WITH MEDICATION GUIDE
10 x 2,000 Units/mL single-dose vials (containing 1 mL)

Phenylketonurics: Contains Phenylalanine,
0.5 mg per mL

For Intravenous or Subcutaneous Use Only

Single-dose vial

Discard unused portion

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 2,000 Units/mL Vial Carton

PRINCIPAL DISPLAY PANEL - 3,000 Units/mL Vial Label

NDC 0069-1306-01
Rx only

Retacrit™
Epoetin Alfa-epbx
recombinant

3,000 Units/mL

1 mL single-dose vial

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 3,000 Units/mL Vial Label

PRINCIPAL DISPLAY PANEL - 3,000 Units/mL Vial Carton

Retacrit™
Epoetin Alfa-epbx
recombinant

3,000 Units/mL

NDC 0069-1306-10
Rx only

ALWAYS DISPENSE WITH MEDICATION GUIDE
10 x 3,000 Units/mL single-dose vials (containing 1 mL)

Phenylketonurics: Contains Phenylalanine,
0.5 mg per mL

For Intravenous or Subcutaneous Use Only

Single-dose vial

Discard unused portion

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 3,000 Units/mL Vial Carton

PRINCIPAL DISPLAY PANEL - 4,000 Units/mL Vial Label

NDC 0069-1307-01
Rx only

Retacrit™
Epoetin Alfa-epbx
recombinant

4,000 Units/mL

1 mL single-dose vial

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 4,000 Units/mL Vial Label

PRINCIPAL DISPLAY PANEL - 4,000 Units/mL Vial Carton

Retacrit™
Epoetin Alfa-epbx
recombinant

4,000 Units/mL

NDC 0069-1307-10
Rx only

ALWAYS DISPENSE WITH MEDICATION GUIDE
10 x 4,000 Units/mL single-dose vials (containing 1 mL)

Phenylketonurics: Contains Phenylalanine,
0.5 mg per mL

For Intravenous or Subcutaneous Use Only

Single-dose vial

Discard unused portion

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 4,000 Units/mL Vial Carton

PRINCIPAL DISPLAY PANEL - 10,000 Units/mL Vial Label

NDC 0069-1308-01
Rx only

Retacrit™
Epoetin Alfa-epbx
recombinant

10,000 Units/mL

1 mL single-dose vial

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 10,000 Units/mL Vial Label

PRINCIPAL DISPLAY PANEL - 10,000 Units/mL Vial Carton

Retacrit™
Epoetin Alfa-epbx
recombinant

10,000 Units/mL

NDC 0069-1308-10
Rx only

ALWAYS DISPENSE WITH MEDICATION GUIDE
10 x 10,000 Units/mL single-dose vials (containing 1 mL)

Phenylketonurics: Contains Phenylalanine,
0.5 mg per mL

For Intravenous or Subcutaneous Use Only

Single-dose vial

Discard unused portion

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 10,000 Units/mL Vial Carton

PRINCIPAL DISPLAY PANEL - 40,000 Units/mL Vial Label

NDC 0069-1309-01
Rx only

Retacrit™
Epoetin Alfa-epbx
recombinant

40,000 Units/mL

1 mL single-dose vial

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 40,000 Units/mL Vial Label

PRINCIPAL DISPLAY PANEL - 40,000 Units/mL Vial Carton

Retacrit™
Epoetin Alfa-epbx
recombinant

40,000 Units/mL

NDC 0069-1309-04
Rx only

ALWAYS DISPENSE WITH MEDICATION GUIDE
4 x 40,000 Units/mL single-dose vials (containing 1 mL)
Phenylketonurics: Contains Phenylalanine, 0.5 mg per mL
For Intravenous or Subcutaneous Use Only
Single-dose vial
Discard unused portion

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 40,000 Units/mL Vial Carton

PRINCIPAL DISPLAY PANEL - 20,000 Units/mL Vial Label

NDC 0069-1311-01
Rx only

Retacrit™
Epoetin Alfa-epbx
recombinant

20,000 Units/mL

1 mL Multiple Dose Vial
Pfizer Oncology

PRINCIPAL DISPLAY PANEL - 20,000 Units/mL Vial Label

PRINCIPAL DISPLAY PANEL - 20,000 Units/mL Vial Carton

ALWAYS DISPENSE ENCLOSED MEDICATION GUIDE TO EACH PATIENT
10 x 20,000 Units/mL multiple dose vials (containing 1 mL)
NDC 0069-1311-10

Retacrit™
Epoetin Alfa-epbx
recombinant

20,000 Units/mL

For Intravenous or Subcutaneous Use Only
Sterile Solution - Preserved
Multiple Dose Vials

Rx only

PRINCIPAL DISPLAY PANEL - 20,000 Units/mL Vial Carton

PRINCIPAL DISPLAY PANEL - 20,000 Units/2 mL Vial Label

NDC 0069-1318-01
Rx only

Retacrit™
Epoetin Alfa-epbx
recombinant

20,000 Units/2 mL
(10,000 Units/mL)

2 mL Multiple Dose Vial
Pfizer Oncology

PRINCIPAL DISPLAY PANEL - 20,000 Units/2 mL Vial Label

PRINCIPAL DISPLAY PANEL - 20,000 Units/2 mL Vial Carton

ALWAYS DISPENSE ENCLOSED MEDICATION GUIDE TO EACH PATIENT
NDC 0069-1318-10
10 x 20,000 Units/2 mL (10,000 Units/mL) multiple dose vials (containing 2 mL)

Retacrit™
Epoetin Alfa-epbx
recombinant

20,000 Units/2 mL (10,000 Units/mL)

For Intravenous or Subcutaneous Use Only
Sterile Solution - Preserved
Multiple Dose Vials
Rx only

PRINCIPAL DISPLAY PANEL - 20,000 Units/2 mL Vial Carton
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

*9AM-5PM ET Monday to Friday; excluding holidays.

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch